Improved Health Outcomes with Peak Flow Monitoring for Children with Asthma

Burkhart, Patricia V.; Rayens, Mary Kay; Revelette, W. R.; Ohlmann, Ashleigh B.

doi:10.1080/02770900601182517

Cited by 14 publications

(18 citation statements)

References 7 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One study found that patients who used PEF to guide therapy when symptomatic had a lower asthma severity score, fewer symptom days and less healthcare utilisation than children who either used PEF daily or evaluated subjective symptoms alone [37]. In an uncontrolled study, in 77 asthmatic children, daily PEF in combination with comprehensive asthma education resulted in a reduction in the number of asthma episodes, medical and emergency department visits, and missed school days [38]. Two randomised controlled studies did not show a benefit of PEF guided treatment compared with management based on symptoms alone, and addition of PEF did not enhance self-management even during acute exacerbations [28,39].…”

Section: Measurement Of Peak Flowmentioning

confidence: 99%

Monitoring asthma in childhood: lung function, bronchial responsiveness and inflammation

et al. 2015

View full text Add to dashboard Cite

This review focuses on the methods available for measuring reversible airways obstruction, bronchial hyperresponsiveness (BHR) and inflammation as hallmarks of asthma, and their role in monitoring children with asthma. Persistent bronchial obstruction may occur in asymptomatic children and is considered a risk factor for severe asthma episodes and is associated with poor asthma outcome. Annual measurement of forced expiratory volume in 1 s using office based spirometry is considered useful. Other lung function measurements including the assessment of BHR may be reserved for children with possible exercise limitations, poor symptom perception and those not responding to their current treatment or with atypical asthma symptoms, and performed on a higher specialty level. To date, for most methods of measuring lung function there are no proper randomised controlled or large longitudinal studies available to establish their role in asthma management in children.Noninvasive biomarkers for monitoring inflammation in children are available, for example the measurement of exhaled nitric oxide fraction, and the assessment of induced sputum cytology or inflammatory mediators in the exhaled breath condensate. However, their role and usefulness in routine clinical practice to monitor and guide therapy remains unclear, and therefore, their use should be reserved for selected cases. @ERSpublications Review on the role of lung function, measurement of BHR and airway inflammation in monitoring of children with asthma

show abstract

Section: Measurement Of Peak Flowmentioning

confidence: 99%

Monitoring asthma in childhood: lung function, bronchial responsiveness and inflammation

et al. 2015

View full text Add to dashboard Cite

show abstract

“…Developed through collaboration between an asthma educator, the health care provider, and the family, action plans have been shown to be of value in older children [105][106][107][108] , although they have not been sufficiently studied in this younger age group. An asthma action plan should contain details that will enable those who care for the child to recognize exacerbations early, and know what interventions are required, including when medical help should be sought.…”

Section: Home Action Plan For Family/caregiversmentioning

confidence: 99%

Global strategy for the diagnosis and management of asthma in children 5 years and younger

Pedersen

Hurd

Lemanske

et al. 2010

Pediatric Pulmonology

270

207

View full text Add to dashboard Cite

Asthma is the most common chronic disease of childhood and the leading cause of childhood morbidity from chronic disease as measured by school absences, emergency department visits, and hospitalions1. During the past two decades, many scientific advances have improved our understanding of asthma and our ability to manage and control it effectively. However, in children 5 years and younger, the clinical symptoms of asthma are variable and non‐specific. Furthermore, neither airflow limitation nor airway inflammation, the main pathologic hallmarks of the condition, can be assessed routinely in this age group. For this reason, to aid in the diagnosis of asthma in young children, a symptoms‐only descriptive approach that includes the definition of various wheezing phenotypes has been recommended2. In 1993, the Global Initiative for Asthma (GINA) was implemented to develop a network of individuals, organizations, and public health officials to disseminate information about the care of patients with asthma while at the same time assuring a mechanism to incorporate the results of scientific investigations into asthma care. Since then, GINA has developed and regularly revised a Global Strategy for Asthma Management and Prevention. Publications based on the Global Strategy for Asthma Management and Prevention have been translated into many different languages to promote international collaboration and dissemination of information.In this report, Global Strategy for Asthma Management and Prevention in Children 5 Years and Younger, an effort has been made to present the special challenges that must be taken into account in managing asthma in children during the first 5 years of life, including difficulties with diagnosis, the efficacy and safety of drugs and drug delivery systems, and the lack of data on new therapies. Approaches to these issues will vary among populations in the world based on socioeconomic conditions, genetic diversity, cultural beliefs, and differences in healthcare access and delivery. Patients in this age group are often managed by pediatricians and general practitioners routinely faced with a wide variety of issues related to childhood diseases. Pediatr Pulmonol. 2011; 46:1–17. © 2010 Wiley‐Liss, Inc.

show abstract

“…When children reach adolescence, they find it more difficult to manage their chronic illnesses. Despite advances in medical technologies in the diagnosis and treatment of asthma, these medical technologies need to be accepted and understood by patients so that they can adhere to the medical regimens prescribed for them (Burkhart, Rayens, Revelette, & Ohlmann, 2007; Lim, Wood, & Miller, 2008; Osterberg & Blaschke, 2005; Sokol, McGuigan, Verbrugge, & Epstein, 2005). In many cases, asthma control relies more on the lifestyle management that helps to control the allergic sources than on the medications alone (Global Initiative for Asthma [GINA], 2007; Madge, McColl, & Paton, 1997; National Heart, Lung, and Blood Institute, 2007; Wolf, Guevara, Grum, Clark, & Cates, 2002).…”

mentioning

confidence: 99%

Parent Support, Peer Support, and Peer Acceptance in Healthy Lifestyle for Asthma Management Among Early Adolescents

Yang¹,

Sylva

Lunt

2010

Journal for Specialists in Pediatric Nursing

View full text Add to dashboard Cite

show abstract

Improved Health Outcomes with Peak Flow Monitoring for Children with Asthma

Abstract: PFM significantly reduced pediatric asthma morbidity in this sample.

Cited by 14 publications

References 7 publications

Monitoring asthma in childhood: lung function, bronchial responsiveness and inflammation

Monitoring asthma in childhood: lung function, bronchial responsiveness and inflammation

Global strategy for the diagnosis and management of asthma in children 5 years and younger

Parent Support, Peer Support, and Peer Acceptance in Healthy Lifestyle for Asthma Management Among Early Adolescents

Contact Info

Product

Resources

About